Descriptive data | 14* | 1) Give characteristics of study participants (e.g. demographic, clinical, social) and information on exposures and potential confounders | NA |
2) Indicate number of participants with missing data for each variable of interest | NA | ||
Outcome data | 15* | Report numbers of outcome events or summary measures | 6 |
Main results | 16 | 1) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (e.g., 95% confidence interval). Make clear which confounders were adjusted for and why they were included | 12 |
2) Report category boundaries when continuous variables were categorized | 12 | ||
3) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period | 12 | ||
Other analyses | 17 | Report other analyses done—e.g. analyses of subgroups and interactions, and sensitivity analyses | 12 |
Discussion | |||
Key results | 18 | Summarise key results with reference to study objectives | 7 |
Limitations | 19 | Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias | 7 |
Interpretation | 20 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence | 7 |
Generalizability | 21 | Discuss the generalizability (external validity) of the study results | NA |
Other information | |||
Funding | 22 | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based | 9 |